title: A case of new-onset antibody-positive myasthenia gravis in a patient treated with pembrolizumab for melanoma.
authors.affiliation: Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.
authors.forename: Iyad
authors.initials: I
authors.lastname: Alnahhas
authors.affiliation: Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.
authors.forename: Jason
authors.initials: J
authors.lastname: Wong
mesh_terms: D000369:Aged, 80 and over; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D003391:Cranial Nerves / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008545:Melanoma / Q000150:complications* / Q000188:drug therapy*; D009157:Myasthenia Gravis / Q000209:etiology* / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C582435:pembrolizumab